Esperion Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.About ESPR
Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets.
ESPR Key Statistics
ESPR News
Esperion Therapeutics (ESPR) just completed a $75 million follow-on equity offering, issuing 30 million shares at $2.50 each. This capital raise comes at a key...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Esperion (ESPR) Therapeutics announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares of common stock in...
Analyst ratings
63%
of 8 ratingsMore ESPR News
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Esperion, with a price target of $16.00. Elevate Your Investing Str...
Esperion (ESPR) announced that it has entered into a settlement agreement with Dr. Reddy’s Laboratories (RDY) and its affiliate Dr. Reddy’s Laboratories. This a...